3-[2-((2S)-2-Cyano-pyrrolidin-1-yl)-2-oxo-ethylamino]-3-methyl-butyramide analogues as selective DPP-IV inhibitors for the treatment of type-II diabetes

MS Coumar, CN Chang, CT Chen, X Chen…

Index: Bioorganic and Medicinal Chemistry Letters, , vol. 17, # 5 p. 1274 - 1279

Full Text: HTML

Citation Number: 12

Abstract

... Please enable JavaScript to use all the features on this page. Bioorganic & Medicinal Chemistry Letters. ... By chemical modification of the lead 5, we obtained 5f with an improved DPP-IV potency (3-fold) and better selectivity (57-fold over DPP8) in comparison to 5. ...

Related Articles:

BMS-187257, a potent, selective, and novel heterocyclic β 3 adrenergic receptor agonist

[Fisher, Liesl G.; Sher, Philip M.; Skwish, Stephen; Michel, Inge M.; Seiler, Steven M.; Dickinson, Kenneth E. J. Bioorganic and Medicinal Chemistry Letters, 1996 , vol. 6, # 19 p. 2253 - 2258]

Probing the Helical Secondary Structure of Short??Chain β??Peptides

[Seebach, Dieter; Ciceri, Paola E.; Overhand, Mark; Jaun, Bernhard; Rigo, Dario; Oberer, Lukas; Hommel, Ulrich; Amstutz, Rene; Widmer, Hans Helvetica Chimica Acta, 1996 , vol. 79, # 8 p. 2043 - 2066]

TAPP analogs containing β3??homo??amino acids: synthesis and receptor binding

[Journal of Peptide Science, , vol. 18, # 9 p. 556 - 559]

TAPP analogs containing β3??homo??amino acids: synthesis and receptor binding

[Journal of Peptide Science, , vol. 18, # 9 p. 556 - 559]

More Articles...